SANA - Former FDA Commissioner Hahn joins VC firm that helped launch Moderna

Chip Somodevilla/Getty Images News Stephen Hahn, an oncologist who served as FDA commissioner as the Trump administration dealt with the COVID-19 pandemic, has joined venture capital firm Flagship Pioneering as a chief medical officer. Hahn will lead Flagship's Preemptive Medicine and Health Security initiative beginning on Wednesday. More than a decade ago, Flagship helped incubate Moderna (MRNA), supporting its efforts to develop mRNA medicines. Since its 2000 launch, Flagship has invested more than $2.4B towards starting and helping grow companies. Other publicly traded companies Flagship has invested in include Denali Therapeutics (DNLI),  Rubius Therapeutics (RUBY), Sana Biotechnology (SANA), and Seres Therapeutics (MCRB).

For further details see:

Former FDA Commissioner Hahn joins VC firm that helped launch Moderna